September 21, 2020—AngioDynamics, Inc. announced the United States commercial launch of the Auryon atherectomy system for the treatment of peripheral artery disease (PAD), including critical limb ischemia (CLI) and in-stent restenosis (ISR).
According to the company, the Auryon atherectomy system uses solid-state laser technology to efficiently treat lesions of any type, length, or location (ie, above and below the knee), with minimal impact on vessel walls. The systems 355-nm wavelength laser platform allows for the use of ultraviolet laser pulses with targeted biologic reactions that are effective in treating PAD while minimizing the risk of perforation and preserving the ability to vaporize lesions without thermal ablation. The system also offers aspiration and off-set capability in certain catheter sizes, which allows clinicians to address the risk of embolization and to treat all lesion types while answering a need for nonsurgical intervention opti...